Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
This study has been completed.
Sponsor:
TheraVasc Inc.
Information provided by (Responsible Party):
TheraVasc Inc.
ClinicalTrials.gov Identifier:
NCT01401517
First received: June 28, 2011
Last updated: February 18, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2013 |
| Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |